Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Oscar, Puig"'
Autor:
Iris Barshack, Ronnie Shapira-Frommer, Kenneth Bloom, Nethanel Asher, Guy Ben-Betzalel, Becky Arbiv, Assaf Debby, Ron Elran, Pinchas Birnbaum, Shai Bookstein, Tal Dankovich, Lena Tsabari, Yuval Shachaf, Yoad Cohen, Amit Bart, Oscar Puig, Ettai Markovits
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f73b7ded66fc4ddda7909f14ed960342
Autor:
Iris Barshack, Ronnie Shapira-Frommer, Kenneth Bloom, Nethanel Asher, Guy Ben-Betzalel, Becky Arbiv, Assaf Debby, Ron Elran, Pinchas Birnbaum, Shai Bookstein, Tal Dankovich, Lena Tsabari, Yuval Shachaf, Yoad Cohen, Amit Bart, Oscar Puig, Ettai Markovits
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/40e74a318ef54b12af57e9a04683fa4b
Autor:
Severine Isabelle Gharbi, Laura A. Pelletier, Alfonso Espada, Jesus Gutiérrez, Sonia Maria Gutiérrez Sanfeliciano, Charles T. Rauch, Maria Patricia Ganado, Carmen Baquero, Elisabet Zapatero, Aiping Zhang, Jordi Benach, Anna-Maria Russell, Leticia Cano, Sandra Gomez, Howard Broughton, Nicholas Pulliam, Carmen Maria Perez, Raquel Torres, Marjoke F. Debets, Alfonso de Dios, Oscar Puig, Mark T. Hilgers, Maria Jose Lallena
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Despite the biological and therapeutic relevance of CDK4/6 for the treatment of HR+, HER2- advanced breast cancer, the detailed mode of action of CDK4/6 inhibitors is not completely understood. Of particular interest, phosphorylation of CDK4
Externí odkaz:
https://doaj.org/article/a4901c8cc1f2445081034949720c4383
Autor:
Xiaoyu Feng, Yangyang Wang, Tao Long, Lanyue Bai, Xiaojiao Yang, Ailing Yang, Xiangmei Chen, Oscar Puig, Yangbo Yue, Zhirong Shen
Publikováno v:
HemaSphere, Vol 7, p e368855c (2023)
Externí odkaz:
https://doaj.org/article/bc61616c75b2469d8c20063d5a6f2a35
Autor:
Severine Isabelle Gharbi, Laura A. Pelletier, Alfonso Espada, Jesus Gutiérrez, Sonia Maria Gutiérrez Sanfeliciano, Charles T. Rauch, Maria Patricia Ganado, Carmen Baquero, Elisabet Zapatero, Aiping Zhang, Jordi Benach, Anna-Maria Russell, Leticia Cano, Sandra Gomez, Howard Broughton, Nicholas Pulliam, Carmen Maria Perez, Raquel Torres, Marjoke F. Debets, Alfonso de Dios, Oscar Puig, Mark T. Hilgers, Maria Jose Lallena
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/3b011c3c5bd0459a9b47a137f7b7d6fd
Autor:
Rasa Santockyte, Chelsea Jin, James Pratt, Ron Ammar, Keyur Desai, Mohan Bolisetty, Prianka Das, Mihaela Popa-McKiver, Oscar Puig
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 4, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/096a954f2b8341f8ab6b45d024cc8712
Autor:
Yanxia Li, Nelusha Amaladas, Marguerita O’Mahony, Jason R. Manro, Ivan Inigo, Qi Li, Erik R. Rasmussen, Manisha Brahmachary, Thompson N. Doman, Gerald Hall, Michael Kalos, Ruslan Novosiadly, Oscar Puig, Bronislaw Pytowski, David A. Schaer
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
Prolonged activation of vascular endothelial growth factor receptor-2 (VEGFR-2) due to mis-regulation of the VEGF pathway induces aberrant blood vessel expansion, which supports growth and survival of solid tumors. Therapeutic interventions that inhi
Externí odkaz:
https://doaj.org/article/9cc71a3eb98c45e392fe26cf507153e3
Autor:
Melanie F. Pradier, Bernhard Reis, Lori Jukofsky, Francesca Milletti, Toshihiko Ohtomo, Fernando Perez-Cruz, Oscar Puig
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Codrituzumab, a humanized monoclonal antibody against Glypican-3 (GPC3), which is expressed in hepatocellular carcinoma (HCC), was tested in a randomized phase II trial in advanced HCC patients who had failed prior systemic therap
Externí odkaz:
https://doaj.org/article/c84e3057b2a241b69d2832c6f9702481
Autor:
Roman Shraga, Sarah Yarnall, Sonya Elango, Arun Manoharan, Sally Ann Rodriguez, Sara L. Bristow, Neha Kumar, Mohammad Niknazar, David Hoffman, Shahin Ghadir, Rita Vassena, Serena H. Chen, Avner Hershlag, Jamie Grifo, Oscar Puig
Publikováno v:
BMC Genetics, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Current professional society guidelines recommend genetic carrier screening be offered on the basis of ethnicity, or when using expanded carrier screening panels, they recommend to compute residual risk based on ethnicity. We inve
Externí odkaz:
https://doaj.org/article/3b3d6e6b49e743de86941d8df101717f
Autor:
Raquel, Torres-Guzmán, Maria Patricia, Ganado, Cecilia, Mur, Carlos, Marugan, Carmen, Baquero, Yanzhu, Yang, Yi, Zeng, Huimin, Bian, Jian, Du, Alfonso, de Dios, Oscar, Puig, María José, Lallena
Publikováno v:
Oncotarget. 13:864-875
Abemaciclib is an oral, selective cyclin-dependent kinase 46 inhibitor (CDK46i), approved for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) as monotherapy for endocrine refract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69dab28f3ef5a47efbcef09588aa74ec
https://doi.org/10.18632/oncotarget.28249
https://doi.org/10.18632/oncotarget.28249